Central clinical research issues in electrophysiology: Report of the NASPE committee

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 4I, 2001, Pages 526-534

  Domanski, Michael J ^a   Zipes, Douglas P ^b   Benditt, David G ^c   Camm, A John ^d   Exner, Derek V ^a   Ezekowitz, Michael D ^e   Greene, H Leon ^f   Lesh, Michael D ^g   Miller, John M ^b   Pratt, Craig M ^h   Saksena, Sanjeev ⁱ   Scheinman, Melvin M ^j   Singh, Bramah N ^k   Tracy, Cynthia M ^l   Waldo, Albert L ^m  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l GEORGETOWN UNIVERSITY   (United States)

^m CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Arrhythmias; Electrophysiology; Research; Syncope

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CLINICAL RESEARCH; CONGESTIVE HEART FAILURE; HEART ARRHYTHMIA; HEART DEATH; HEART DILATATION; HEART ELECTROPHYSIOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL SOCIETY; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SYNCOPE;

ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; HUMANS; PACEMAKER, ARTIFICIAL; RESEARCH;

EID: 0035033855     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.00526.x     Document Type: Review

References (65)

1. Sudden death: Epidemiology, transient risk, and intervention assessment
2. Sudden cardiac death
3. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
4. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias
5. A randomized study of prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial
6. Interpretation of outcomes in antiarrhythmic clinical trials: Design features and population impact
7. Out-of-hospital cardiac arrest in the 1990's: A population-based study in the Maastricht area on incidence, characteristics and survival
8. Antiarrhythmics and mortality in congestive heart failure
9. Primary prevention of sudden cardiac death in heart failure: Will the solution be shocking
10. Risk stratification and survival after myocardial infarction
11. Prognostic significance of left ventricular ejection fraction after acute myocardial infarction. A bedside radionuclide study
12. Prognostic implications of asymptomatic ventricular arrhythmias: The Framingham Heart Study
13. Risk stratification after acute myocardial infarction
14. Evaluating patients with ventricular arrhythmia. Role of the signal-averaged electrocardiogram, exercise test, ambulatory electrocardiogram, and electrophysiologic studies
15. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction
16. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction?
17. The role of signal-averaged electrocardiography in identifying patients at high risk for lethal ventricular tachyarrhythmias
18. Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a task force committee of the European Society of Cardiology
19. QT interval dispersion and its clinical utility
20. Will QT dispersion play a role in clinical decision-making?
21. Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects
22. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction
23. QT dispersion and ventricular fibrillation in acute myocardial infarction
24. QT dispersion does not predict early ventricular fibrillation after acute myocardial infarction
25. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction
26. Baroreflex sensitivity as a cardiac and arrhythmia mortality risk stratifier
27. Baroreflex sensitivity in patients with mild to moderate heart failure
28. Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death
29. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart)
30. Repolarization alternans: Techniques, mechanisms, and cardiac vulnerability
31. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
32. Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients
33. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease
34. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by Purkinje potential
35. Syncope in a general hospital population
36. Prospective evaluation of syncope
37. Syncope: Physiological considerations and an analysis of the clinical characteristics in 510 patients
38. Epidemiologic feature of isolated syncope: The Framingham Study
39. A prospective evaluation and follow-up of patients with syncope
40. Prevalence of cardioinhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to the accident and emergency department with "unexplained" or "recurrent" falls
41. Neurally mediated syncopal syndromes: Pathophysiology and clinical evaluation
42. Syncope associated with supraventricular tachycardia: An expression of tachycardia or vasomotor response
43. Evaluation and outcome of patients with syncope
44. Differentiation of convulsive syncope and epilepsy with head-up tilt table testing
45. Intracardiac electrophysiologic techniques in recurrent syncope of unknown cause
46. Role of electrophysiologic studies in patients with unexplained recurrent syncope
47. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing
48. Assessment of the hemodynamic responses to single passive head-up tilt by non-invasive methods in normotensive subjects
49. The incidence of malignant vasovagal syndrome in patients with recurrent syncope
50. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study
51. Utility of upright tilt table testing in the evaluation and management of syncope of unknown origin
52. Recurrent unexplained syncope in the elderly: The use of head-upright tilt-table testing in evaluation and management
53. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope
54. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
55. Atrial fibrillation: Role of arrhythmogenic foci
56. Atrial fibrillation follow-up investigation of rhythm management - The AFFIRM study design
57. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy
58. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
59. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study
60. The acute hemodynamic effects of right ventricular septal pacing in patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
61. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study
62. What is the role of pacing in dilated cardiomyopathy?
63. Four chamber pacing in dilated cardiomyopathy
64. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure
65. Multisite pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc. InSync study